Monday, 16 July 2012

Tumor Cells In Mice Killed By Mediterranean Weed Drug


While grenades have been mentioned in situations related to the military, they have never been mentioned in scientific research dealing with cancer. That is, until now. A new innovative drug by researchers at the Johns Hopkins Kimmel Cancer Center, in collaboration with Danish scientists, works like a “molecular grenade”; it can move through the bloodstream until activation by specific cancer proteins.
The drug is made from a weed-like plant that has demonstrated its ability to destroy cancer and direct blood sources, working and safeguarding healthy blood tissues and vessels.  The drug, G202, is made from Thapsia gargancia, a weed that grows in the Mediterranean area. The plant produces thapsigargin, a product that has been known to be toxic to animals.
The investigators stated that, through laboratory studies, they tested a three-day course of drug G202. Within 30 days, the drug can decrease the size of human prostate tumors found in mice to about 50%. When compared to chemotherapy drug docetaxel, G202 outperformed it and reduced seven of nine human prostate tumors in a 21-day period.
Apart from the study done with tumors, G202 was able to produce regression in illness like bladder cancer, breast cancer, and kidney cancer. The findings are presented in a recent issue of the journal Science Translational Medicine.

No comments:

Post a comment

You only need to enter your comment once! Comments will appear once they have been moderated. This is so as to stop the would-be comedian who has been spamming the comments here with inane and often offensive remarks. You know who you are!

Related Posts with Thumbnails

ShareThis